The Asubio Business Model

Asubio Pharmaceuticals, Inc. (Asubio) is an R&D based company located in New Jersey.

Asubio is committed to the early stage clinical development of innovative ethical pharmaceuticals, discovered through chemical synthesis, biotechnology and peptide chemistry, originating from the company's discovery laboratories in Japan. These research candidates are then licensed to companies for late-stage development and commercialization in the United States and world markets.

The strength of Asubio rests in the diverse scientific knowledge, expertise and the team work of our clinical development teams. Our management and scientists have extensive backgrounds and experience in conducting clinical trials and preparing pharmaceutical products for commercialization.

At Asubio, we pride ourselves on our commitment to establish solid, secure, science-oriented relationships with investigators and extended teams, including clinical research organizations, consultants and business partners. Our team is proud to be on the cutting edge of clinical development technology and responsible for the worldwide development of an exciting product pipeline outside Japan.